Medidata Blog

June 9 Media Roundup

Reading Time: 2 minutes

Here’s what you missed in recent industry news. Follow us on Twitter and LinkedIn for the latest in how technology is transforming life sciences.

Neuroscience, meet Donkey Kong. Can microprocessors help us understand inner workings of the brain?

Creating a universal cancer vaccine.

Research shows women in tech perform just as well—if not better—than male counterparts.

FDA’s Center for Device and Radiological Health is supporting development ofa wearable kidney.

Project “HGP-write, “a project to synthesize human and other complete genomes from off-the-shelf parts.”

Vice President Biden announces the launch of the first-of-its kind, open-access cancer research database.

Congrats to Stat News on launching the biotech newsletter “The Readout!

A 28 year old is transforming access to medicine in remote areas with invention of atouchscreen heart monitor.

Boston Children’s Hospital, Duke Health, and Intermountain Health have adopt new HL7 tech to enhance data access.

Congrats to all Women in Tech winners on the Forbes’ 100 Most Powerful Women list!

Daniel Goldin is a man on a mission. The former head of the National Aeronautics and Space Administration wants to fundamentally change the computing world. His California-based company, KnuEdge, is advancing its brain-like neural chip. “The human brain has a couple of hundred billion neurons, and each neuron is connected to at least 10,000 to 100,000 neurons,” Goldin said. “And the brain is the most energy efficient and powerful computer in the world. That is the metaphor we are using.”

A program in Ghana is using mobile phones to expand healthcare access.

Two students have developed an algorithm capable of detecting human emotion.

Two blood-based biomarkers could help bring personalized medicine to depression.

Inspired by nature, a team of chemists at MIT are exploring fungus in the fight against cancer. Because little is known about how some chemical reactions and pathways are actually formed in nature, the researchers must use both scientific principles as well as creativity and intuition to synthesize communesins, a group of fungal compounds that hold potential as anticancer agents.

Geeks Talk Clinical